Strokes in children
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.001Keywords
stroke, children, pediatryAbstract
Introduction and purpose
A stroke is a group of neurological symptoms that develops when blood flow to the brain is stopped suddenly. Stroke is relatively rare in the group of pediatric patients. The incidence is estimated at 2.5 cases per 100,000 children per year. Mortality is up to 4%. Long-term consequences and complications concern more than half of the patients.
Brief description of the state of knowledge
The etiopathogenesis of stroke in children is diverse. The main risk factors are congenital heart disease, vascular damage, metabolic diseases and infections. The symptoms of a stroke depend on the location and extent of the ischemic changes. In children they may initially be uncharacteristic. The most common are headaches, vomiting, convulsions, disturbed consciousness, and hemiparesis. The gold standard in cerebral ischemia imaging is brain magnetic resonance angiography (MRA). In treatment controlling vital parameters plays an important role. Treatment includes anti-aggregating and anticoagulant drugs. It is possible to transfuze blood or surgical treatment. Complications of stroke in children are diversify and depend on a lot of factors. These include movement disorders, cognitive functions impairment, tension headaches and difficulty with expression and fluency of speech.
Conclusion
A stroke is a life-threatening condition that requires immediate treatment. It can have uncharacteristic symptoms in children. Acute cerebral ischemia in children carries the risk of developing long-term, severe complications. Pediatric patients with a history of acute cerebral ischemia should be under the constant care of specialized treatment and rehabilitation centers, which will enable patients to function independently among their peers.
References
Gandhi SK, McKinney JS, Sedjro JE, et al. Temporal trends in incidence and long-term case fatality of stroke among children from 1994 to 2007. Neurology. 2012;78:1923–9
Schoenberg B.S., Mellinger J.F., Schoenberg D.G.: Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival. Neurology 1978, 28, 763–768.
Lynch J.K., Hirtz D.G., De Veber G. et al.: Report on the National Institute ofNeurological Disorders and Stroke Workshop on Perinatal and Childhood Stroke. Pediatrics 2002;109:116–123.
Guimaraes I.E., Ciasca S.M., Moura-Ribeiro M.V.: Neuropsychological evaluation of children after ischemic cerebrovascular disease. Arq Neuropsiquiatr 2002;60:386–389.
Hajek CA, Yeates KO, Anderson V, et al. Cognitive Outcomes Following Arterial Ischemic Stroke in Infants and Children. J Child Neurol. 2013
Roach E.S., Golomb M.R., Adams R. et al.: Management of stroke in infants and children: A scientific statement from a Special Writing Group of American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008;39:2644–2691.
Riela A.R., Roach E.S.: Etiology of stroke in children. J. Child. Neurol. 1993, 8, 201–220.
Ho J., Pacaud D., Hill M.D. et al.: Diabetic ketoacidosis and pediatric stroke. CMAJ 2005;172:327–328.
] Pilarska E., Lemka M., Bąkowska A.: Przeciwciała antyfosfolipidowe oraz trombomodulina u dzieci z udarem niedokrwiennym mózgu. Ann Acad Med Geda 2006;36:139–145.
Albucher J.F., Ferrieres J., Ruidavets J.B. i wsp.: Serum lipids inyoung patients with ischemic stroke: a case-control study.
de Veber G., Monagle P., Chan A. et al.: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol
Bonduel M., Sciuccati G., Hepner M. et al.: Prethrombotic disorders inchildren with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol 1999;56:967–971.
Cardo E., Vilaseca M.A., Campistol J. et al.: Evolution of hyperhomocysteinemia in children with stroke. Eur J Paediatr Neurol 1999;3:113–117.
Beslow L.A., Linds A.B., Fox C.K., Kossorotoff M., Zuñiga Zambrano Y.C., Hernández-Chávez M., Hassanein S.M.A., Byrne S., Lim M., Maduaka N., Zafeiriou D., Dowling M.M., Felling R.J., Rafay M.F., Lehman L.L., Noetzel M.J., Bernard T.J., Dlamini N. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann. Neurol. 2020 doi: 10.1002/ana.25991. [PubMed] [CrossRef] [Google Scholar]
Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., Singh A.R., Li S., Tarquinio K.M., Jaggi P., Oster M.E., Zackai S.P., Gillen J., Ratner A.J., Walsh R.F., Fitzgerald J.C., Keenaghan M.A., Alharash H., Doymaz S., Clouser K.N., Giuliano J.S., Gupta A., Parker R.M., Maddux A.B., Havalad V., Ramsingh S., Bukulmez H., Bradford T.T., Smith L.S., Tenforde M.W., Carroll C.L., Riggs B.J., Gertz S.J., Daube A., Lansell A., Coronado Munoz A., Hobbs C.V., Marohn K.L., Halasa N.B., Patel M.M., Randolph A.G. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020;383:334–346. doi: 10.1056/nejmoa2021680. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Franchini M., Marano G., Cruciani M., Mengoli C., Pati I., Masiello F., Veropalumbo E., Pupella S., Vaglio S., Liumbruno G.M. COVID-19-associated coagulopathy. Diagnosis. 2020;7:357–363. doi: 10.1515/dx-2020-0078. [PubMed] [CrossRef] [Google Scholar]
Agrawal A., Joharapurkar S.R., Harde P.: Ischemic stroke in childmistaken as functional disorder. Clinical Neurology and Neurosurgery 2007;109:876–879.
Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain & development. 2003;25:416–421. [PubMed] [Google Scholar]
Current concepts in pediatric stroke Andrea Andrade et al. Indian J Pediatr. 2015 Feb.
Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (Clinical research ed) 1997;314:1303–1306. [PMC free article] [PubMed] [Google Scholar]
Carpenter J., Tsuchida T., Lynch T.: Treatment of arterial ischemic stroke in children. Expert Rev Neurother 2007;7:383–392. 1998;55:1539–1543
Adams RJ, Brambilla D. Optimizing Primary Stroke Prevention in Sickle Cell Anemia Trial I., Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. The New England Journal of Medicine. 2005;353:2769–2778.
Amlie-Lefond C, et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet neurology. 2009;8:530–536.
Smith SE, et al. Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children. Developmental medicine and child neurology. 2011;53:29–33. [PubMed] [Google Scholar] [Ref list]
Rabinstein AA, Atkinson JL, Wijdicks EF. Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose? Neurology. 2002;58:1367–1372.
Hogan AM, Kirkham FJ, Isaacs EB. Intelligence after stroke in childhood: review of the literature and suggestions for future research. Journal of child neurology. 2000;15:325–332.
Yang JS, Park YD, Hartlage PL. Seizures associated with stroke in childhood. Pediatric neurology. 1995;12:136–138.
Steinlin M., Roellin K., Schroth G.: Long-term follow after stroke in childhood. Eur J Pediatr 2004;163:245–250.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Wiktoria Sielwanowska, Monika Żybowska, Anna Rzewuska, Bartłomiej Syzdoł, Magdalena Chrościńska-Krawczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 680
Number of citations: 0
